DNAJC5 and malaria: In addition to the central repeat (NANP18), highly neutralizing anti-CSP antibodies engage the junctional residues between the N-terminal domain and repeat region [8], suggesting that these residues need to be considered in the structure-based design of the next generation CSP malaria vaccine.